Get the Stockscreener App
1.49
0.00%
0.00
Anavex Life Sciences Corp stock is traded at $1.49, with a volume of 873.56K.
It is up +0.00% in the last 24 hours and down -38.93% over the past month.
Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.
See More
Previous Close:
$1.49
Open:
$1.5
24h Volume:
873.56K
Relative Volume:
0.56
Market Cap:
$138.12M
Revenue:
Net Income/Loss:
$-39.95M
P/E Ratio:
-3.205
EPS:
-0.4649
Net Cash Flow:
$-34.08M
1W Performance:
-3.25%
1M Performance:
-38.93%
6M Performance:
-54.01%
1Y Performance:
-83.50%
1-Day Range:
$1.47
$1.54
1-Week Range:
$1.44
$1.55
52-Week Range:
$1.44
$9.50
Anavex Life Sciences Corp Stock (AVXL) Company Profile
Name
Anavex Life Sciences Corp
Sector
Industry
Phone
844-689-3939
Address
630 5TH AVENUE, NEW YORK
Compare AVXL vs VRTX, MRNA, REGN, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AVXL
Anavex Life Sciences Corp
|
1.49 | 138.12M | 0 | -39.95M | -34.08M | -0.4649 |
VRTX
Vertex Pharmaceuticals Inc
|
508.71 | 128.94B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
238.63 | 95.27B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
799.98 | 82.36B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
855.28 | 53.79B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
374.53 | 42.37B | 5.76B | 514.49M | 1.10B | 4.4813 |
Anavex Life Sciences Corp Stock (AVXL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-04-26 | Initiated | Rodman & Renshaw | Buy |
| Dec-06-22 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-23-22 | Initiated | Berenberg | Buy |
| Sep-23-21 | Initiated | BTIG Research | Buy |
| Dec-16-20 | Reiterated | H.C. Wainwright | Buy |
| Sep-28-20 | Initiated | Ladenburg Thalmann | Buy |
| Feb-27-20 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-18-19 | Initiated | Janney | Buy |
| May-16-18 | Resumed | Maxim Group | Buy |
| Mar-08-18 | Initiated | ROTH Capital | Buy |
| Feb-13-18 | Reiterated | Maxim Group | Buy |
| Sep-29-17 | Resumed | Noble Financial | Buy |
| Feb-07-17 | Initiated | Noble Financial | Buy |
| Mar-29-16 | Initiated | FBR Capital | Outperform |
View All
Anavex Life Sciences Corp Stock (AVXL) Latest News
AVXL Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Anavex Life Sciences Corp. Class Action Lawsuit - GlobeNewswire Inc.
Class action lawsuit filed against Anavex Life Sciences over CEO firing and financial control issues. - Pluang
Deadline Alert: Anavex Life Sciences Corp. (AVXL) - GlobeNewswire
Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire
Anavex Life Sciences Corp. (AVXL) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Morningstar
AVXL INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Anavex Life Sciences Corp. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Anavex Life Sciences Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AVXL - GlobeNewswire Inc.
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionARDX - GlobeNewswire Inc.
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Anavex Life Sciences Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AVXL - GlobeNewswire Inc.
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Anavex Life - GlobeNewswire
Deadline Alert: Anavex Life Sciences Corp. (AVXL) Shareholders Wh - The National Law Review
Anavex Life Sciences Corp. (AVXL) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
AVXL SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Anavex Life Sciences Corp. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of November 30, 2026 in Anavex Life Sciences Corp. LawsuitAVXL - Morningstar
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of November 30, 2026 in Anavex Life Sciences Corp. LawsuitAVXL - TradingView
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of November 30, 2026 in Anavex Life Sciences Corp. LawsuitAVXL - PR Newswire
AVXL INVESTORS: Contact Kirby McInerney LLP About the Securities Fraud Lawsuit Filed on Behalf of Anavex Life Sciences Corp. Shareholders - GlobeNewswire Inc.
AVXL INVESTORS: Contact Kirby McInerney LLP About the - GlobeNewswire
AVXL INVESTORS: Contact Kirby McInerney LLP About the - GlobeNewswire
Kaplan Fox Encourages Investors of Anavex Life Sciences Corp. (NA - The National Law Review
Kaplan Fox Encourages Investors of Anavex Life Sciences Corp. (NASDAQ: AVXL) to Contact the Firm to Learn About Their Legal Rights - FinancialContent
Levi & Korsinsky Reminds Anavex Life Sciences Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 30, 2026AVXL - PR Newswire
AVXL FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Anavex (A - The National Law Review
Deadline Soon: Anavex Life Sciences Corp. (AVXL) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit - Business Wire
AVXL Investors Have Opportunity to Lead Anavex Life Sciences Corp. Securities Fraud Lawsuit with SBS Law - GlobeNewswire
Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Tigo Energy, Inc. (TYGO), Fluence Energy, Inc. (FLNC), and Anavex Life Sciences Corp. (AVXL) Announced by Holzer & Holzer, LLC - GlobeNewswire Inc.
Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire
November 30, 2026 Deadline Approaching: Join Class Action Against Anavex Life Sciences Corp (AVXL) – Contact Levi & Korsinsky - ACCESS Newswire
Anavex Life Sciences Corp (AVXL) LawsuitInvestors Urged to Contact Levi & Korsinsky Before November 30, 2026 - ACCESS Newswire
AVXL Investors Have Opportunity to Lead Anavex Life Sciences Corp. Securities Fraud Lawsuit Filed by The Rosen Law Firm - Westerly Sun
AVXL Investors Have Opportunity to Lead Anavex Life Sciences Corp. Securities Fraud Lawsuit Filed by The Rosen Law Firm - The Conway Daily Sun
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Qfin Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionQFIN - GlobeNewswire Inc.
ANAVEX CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
ANAVEX CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Anavex Life Sciences Corp. and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman LLC Urges Anavex Life Sciences Corp. Investors to Act: Class Action Filed Alleging Investor Harm - PR Newswire
AVXL Shareholder Alert: November 30, 2026 Lead Plaintiff - GlobeNewswire
Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages Anavex Life Sciences Corp. (AVXL) Shareholders To Inquire About Securities Fraud Class Action - Business Wire
Portnoy Law Firm Announces Class Action on Behalf of Anavex Life Sciences Corp. Investors - GlobeNewswire
Important Notice to Long-Term Shareholders of Anavex Life - GlobeNewswire
AVXL Investor Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Filed Against Anavex Life Sciences Corp. - PR Newswire
ROSEN, THE FIRST FILING FIRM, Encourages Anavex Life - GlobeNewswire
ROSEN, THE FIRST FILING FIRM, Encourages Anavex Life Sciences Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AVXL - GlobeNewswire Inc.
AVXL Investors Have Opportunity to Lead Anavex Life Sciences Corp. Securities Fraud Lawsuit with SBS Law - GlobeNewswire
Law Offices of Frank R. Cruz Encourages Anavex Life Sciences Corp. (AVXL) Shareholders To Inquire About Securities Fraud Class Action - Business Wire
Securities Fraud Investigation Into Anavex Life Sciences Corp. (A - The National Law Review
Bronstein, Gewirtz & Grossman LLC Urges Anavex Life Sciences Corp. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman LLC Urges Anavex Life - GlobeNewswire
Securities Class Action Filed Against Anavex Life Sciences Corp. – AVXL Investors Encouraged to Contact Kirby McInerney LLP - Business Wire
Securities Fraud Investigation Into Anavex Life Sciences Corp. (AVXL) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - Business Wire
Anavex Life Sciences Corp. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your Rights – AVXL - Carroll County Mirror-Democrat
Anavex Life Sciences Corp Stock (AVXL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):